This week, the FDA opened applications for its Expedited IND Pilot, quality experts presented at the PDA/FDA Joint Regulatory Conference, and Hovione expanded its spray drying capacity.
|Articles|September 17, 2010
KIMBERLY-CLARK PROFESSIONAL
With the KIMTECH PURE* G3 Sterile STERLING* Nitrile Gloves, KIMBERLY-CLARK PROFESSIONAL* has introduced a low-cost sterile nitrile glove combining the sensitivity of latex with the protection of nitrile.
Advertisement
Engineered for Protection. Designed for Comfort.
KIMTECH PURE* G3 Sterile STERLING* Nitrile Gloves
KIMBERLY-CLARK PROFESSIONAL* has perfected a low-cost sterile nitrile glove combining the sensitivity of latex with the protection of nitrile. Our innovative STERLING* gloves manufacturing technology enables us to deliver a comfortable and affordable glove with all the protection and cleanliness our customers have come to expect.
When double-donned, the KIMTECH PURE* G3 Sterile STERLING* Nitrile Gloves deliver the equivalent feel & dexterity of a single latex glove without the risk of Type I latex allergic reactions. Protection has never been so comfortable.
The KIMTECH PURE* G3 Sterile STERLING* Nitrile Glove is also environmentally responsible. We have improved packaging to deliver 50% more gloves per case than traditional gloves. Average use of 25 cases per month results in reduction of 1 ton of waste per year vs. traditional latex gloves.
Quality standards
- PPE Category III product classified by EC Council Directive 89/686/EED
- Tested in accordance with EN Norms EN 420-2003
- Cleanroom packaged to meet the needs of Class 100 Cleanrooms
- Meets or exceeds AQL level of 1.5 for pinholes
- Manufactured in accordance with quality System ISO 9001
- Online Trend Data demonstrates product quality over time
For further information, please send an e-mail to
Advertisement
Related to this article
Christy Owings, Thermo Fisher, explains clinical trial supply chain risks in Latin America, importer-of-record strategy, AI, and eCOA delays.
PharmTech AI Pulse Check debuts: pharma experts tackle GxP 'slop,' multi-agent validation risk, OCR document mining, personalized mRNA cancer therapy.
Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Advertisement
Advertisement